Market Closed -
Bombay S.E.
11:00:50 03/05/2024 BST
|
5-day change
|
1st Jan Change
|
559
INR
|
-0.10%
|
|
+0.35%
|
-0.52%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7,081
|
4,604
|
6,967
|
15,494
|
20,204
|
41,949
|
Enterprise Value (EV)
1 |
7,532
|
4,375
|
6,261
|
12,753
|
17,374
|
39,141
|
P/E ratio
|
14.3
x
|
7.05
x
|
7.52
x
|
10.8
x
|
12
x
|
20.6
x
|
Yield
|
0.7%
|
1.13%
|
1%
|
0.77%
|
0.61%
|
0.37%
|
Capitalization / Revenue
|
0.68
x
|
0.4
x
|
0.47
x
|
1.07
x
|
1.28
x
|
2.11
x
|
EV / Revenue
|
0.72
x
|
0.38
x
|
0.42
x
|
0.88
x
|
1.1
x
|
1.97
x
|
EV / EBITDA
|
9.68
x
|
4.05
x
|
4.82
x
|
6.45
x
|
8.41
x
|
15.7
x
|
EV / FCF
|
-12.9
x
|
6.66
x
|
27.8
x
|
8.51
x
|
-68.4
x
|
-81.8
x
|
FCF Yield
|
-7.78%
|
15%
|
3.59%
|
11.8%
|
-1.46%
|
-1.22%
|
Price to Book
|
2.88
x
|
1.77
x
|
1.97
x
|
3.06
x
|
3.08
x
|
5.03
x
|
Nbr of stocks (in thousands)
|
142,288
|
115,659
|
115,659
|
118,598
|
122,930
|
122,930
|
Reference price
2 |
49.76
|
39.80
|
60.24
|
130.6
|
164.4
|
341.2
|
Announcement Date
|
13/08/18
|
02/08/19
|
27/08/20
|
29/07/21
|
09/08/22
|
11/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10,459
|
11,623
|
14,798
|
14,495
|
15,769
|
19,896
|
EBITDA
1 |
778.2
|
1,080
|
1,298
|
1,979
|
2,065
|
2,488
|
EBIT
1 |
651.9
|
888.2
|
1,130
|
1,786
|
1,867
|
2,280
|
Operating Margin
|
6.23%
|
7.64%
|
7.64%
|
12.32%
|
11.84%
|
11.46%
|
Earnings before Tax (EBT)
1 |
662.2
|
1,018
|
1,307
|
1,950
|
2,173
|
2,587
|
Net income
1 |
401.8
|
652.6
|
934.8
|
1,439
|
1,628
|
1,967
|
Net margin
|
3.84%
|
5.61%
|
6.32%
|
9.93%
|
10.32%
|
9.89%
|
EPS
2 |
3.474
|
5.642
|
8.010
|
12.14
|
13.73
|
16.59
|
Free Cash Flow
1 |
-585.9
|
657.1
|
224.8
|
1,499
|
-253.9
|
-478.4
|
FCF margin
|
-5.6%
|
5.65%
|
1.52%
|
10.34%
|
-1.61%
|
-2.4%
|
FCF Conversion (EBITDA)
|
-
|
60.85%
|
17.32%
|
75.77%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
100.69%
|
24.05%
|
104.16%
|
-
|
-
|
Dividend per Share
2 |
0.3500
|
0.4500
|
0.6000
|
1.000
|
1.000
|
1.250
|
Announcement Date
|
13/08/18
|
02/08/19
|
27/08/20
|
29/07/21
|
09/08/22
|
11/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
451
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
229
|
706
|
2,742
|
2,830
|
2,808
|
Leverage (Debt/EBITDA)
|
0.5792
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-586
|
657
|
225
|
1,499
|
-254
|
-478
|
ROE (net income / shareholders' equity)
|
21.3%
|
28.3%
|
30%
|
32.9%
|
27.9%
|
26.2%
|
ROA (Net income/ Total Assets)
|
4%
|
4.98%
|
5.55%
|
7.9%
|
7.61%
|
7.99%
|
Assets
1 |
10,037
|
13,110
|
16,856
|
18,218
|
21,403
|
24,611
|
Book Value Per Share
2 |
17.30
|
22.50
|
30.60
|
42.70
|
53.30
|
67.80
|
Cash Flow per Share
2 |
5.810
|
3.910
|
8.550
|
7.770
|
13.80
|
14.30
|
Capex
1 |
292
|
307
|
320
|
300
|
500
|
598
|
Capex / Sales
|
2.79%
|
2.64%
|
2.17%
|
2.07%
|
3.17%
|
3.01%
|
Announcement Date
|
13/08/18
|
02/08/19
|
27/08/20
|
29/07/21
|
09/08/22
|
11/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -0.52% | 824M | | +12.65% | 8.81B | | +36.64% | 2.38B | | -9.82% | 1.06B | | +11.49% | 802M | | +9.40% | 635M | | -11.56% | 624M | | +10.86% | 617M | | -4.66% | 577M | | +3.62% | 515M |
Purification & Treatment Equipment
|